Tag: NUZ-001 tablets
Neurizon begins manufacturing first NUZ-001 registration batch for NDA submission
Neurizon Therapeutics Limited has announced it has commenced manufacturing the first registration batch of NUZ-001 tablets, marking what it described as a significant milestone in its pathway toward regulatory submission and commercialisation.
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
